New Key Statistics Module, Z-Score and F-Score
SZSE:301333 Key Ratios
Market Cap ¥ M | 4,486.08 |
Enterprise Value ¥ M | 2,800.79 |
P/E(ttm) | 23.13 |
PE Ratio without NRI | 23.07 |
Forward PE Ratio | -- |
Price/Book | 2.53 |
Price/Sales | 5.68 |
Price/Free Cash Flow | 23.50 |
Price/Owner Earnings | 33.48 |
Payout Ratio % | 0.12 |
Revenue (TTM) ¥ M | 737.00 |
EPS (TTM) ¥ | 2.02 |
Beneish M-Score | -1.11 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 6.10 |
y-y EBITDA Growth Rate % | 2.40 |
EV-to-EBIT | 16.67 |
EV-to-EBITDA | 16.67 |
PEG | 3.78 |
Shares Outstanding M | 96.00 |
Net Margin (%) | 21.25 |
Operating Margin % | 19.27 |
Pre-tax Margin (%) | 24.02 |
Quick Ratio | 5.72 |
Current Ratio | 5.90 |
ROA % (ttm) | 7.70 |
ROE % (ttm) | 9.23 |
ROIC % (ttm) | 39.20 |
Dividend Yield % | 0.53 |
Altman Z-Score | 8.36 |
SZSE:301333 Number of Guru Trades
SZSE:301333 Volume of Guru Trades
Gurus Latest Trades with SZSE:301333
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301333 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
R&G PharmaStudies Co Ltd Insider Transactions
No Available Data